$NTRP
NextTrip, Inc. Stock $ntrp

$ntrp Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223028422 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$142.0K	$97.04K	$236.7K
YoY Change	-24.57%	-58.99%	64.18%
Cost Of Revenue	$176.1K	$36.49K	$193.1K
YoY Change	120.94%	-81.1%	65.88%
Gross Profit	-$34.13K	$60.55K	$43.59K
YoY Change	-131.45%	38.93%	57.06%
Gross Profit Margin	-24.04%	62.4%	18.42%
Selling, General & Admin	$690.0K	$938.9K	$1.800M
YoY Change	-64.43%	-47.85%	20.21%
% of Gross Profit		1550.55%	4130.76%
Research & Development	$245.00	$105.3K	$146.9K
YoY Change	-99.84%	-28.34%	-47.67%
% of Gross Profit		173.83%	337.01%
Depreciation & Amortization	$24.55K	$21.47K	$29.86K
YoY Change	-8.58%	-28.1%	15.82%
% of Gross Profit		35.46%	68.51%
Operating Expenses	$866.2K	$1.365M	$2.279M
YoY Change	-63.8%	-40.14%	5.11%
Operating Profit	-$900.3K	-$1.304M	-$2.236M
YoY Change	-60.59%	-41.68%	4.43%
Interest Expense	$3.235K	$3.235K	$2.070K
YoY Change	63.55%	56.28%	2.02%
% of Operating Profit
Other Income/Expense, Net	$28.67K	-$4.075K	-$11.33K
YoY Change	-463.6%	-64.03%	-103.84%
Pretax Income	-$871.7K	-$1.308M	-$2.247M
YoY Change	-61.97%	-41.79%	21.76%
Income Tax
% Of Pretax Income
Net Earnings	-$871.7K	-$1.308M	-$2.247M
YoY Change	-61.97%	-41.79%	21.76%
Net Earnings / Revenue	-613.9%	-1347.95%	-949.54%
Basic Earnings Per Share	-$1.57	-$0.12	-$0.22
Diluted Earnings Per Share	-$1.57	-$0.12	-$214.0K
COMMON SHARES
Basic Shares Outstanding	10.77M shares	10.77M shares	10.50M shares
Diluted Shares Outstanding	560.3K shares	10.77M shares	10.50M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$560.0K	$368.4K	$6.934M
YoY Change	-88.33%	-94.69%	-52.93%
Cash & Equivalents	$556.1K	$368.4K	$6.933M
Short-Term Investments
Other Short-Term Assets	$40.00K	$137.1K	$131.5K
YoY Change	-77.49%	4.28%	-21.89%
Inventory	$775.1K	$940.0K	$783.7K
Prepaid Expenses	$37.83K	$137.1K	$131.5K
Receivables	$59.00K	$45.45K	$291.8K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.428M	$1.491M	$8.140M
YoY Change	-77.38%	-81.68%	-49.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$162.0K	$227.8K	$265.7K
YoY Change	-33.85%	-14.26%	68.7%
Goodwill
YoY Change
Intangibles	$1.248M	$1.215M
YoY Change	15.08%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.410M	$1.443M	$1.295M
YoY Change	6.07%	11.44%	36.18%
TOTAL ASSETS
Total Short-Term Assets	$1.428M	$1.491M	$8.140M
Total Long-Term Assets	$1.410M	$1.443M	$1.295M
Total Assets	$2.838M	$2.934M	$9.435M
YoY Change	-62.87%	-68.9%	-44.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$607.2K	$300.6K	$240.4K
YoY Change	50.47%	25.03%	-23.87%
Accrued Expenses	$145.3K	$115.2K	$253.8K
YoY Change	-49.48%	-54.6%	37.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$863.6K	$542.9K	$624.9K
YoY Change	5.2%	-13.11%	10.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$863.6K	$542.9K	$624.9K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$863.6K	$542.9K	$624.9K
YoY Change	5.2%	-13.11%	-10.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$53.41M	-$52.52M	-$45.08M
YoY Change	12.71%	16.52%
Common Stock	$652.00	$10.77K	$10.50K
YoY Change	-93.79%	2.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.974M	$2.391M	$8.811M
YoY Change
Total Liabilities & Shareholders Equity	$2.838M	$2.934M	$9.435M
YoY Change	-62.87%	-68.9%	-44.78%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$871.7K	-$1.308M	-$2.247M
YoY Change	-61.97%	-41.79%	21.76%
Depreciation, Depletion And Amortization	$24.55K	$21.47K	$29.86K
YoY Change	-8.58%	-28.1%	15.82%
Cash From Operating Activities	-$180.0K	-$1.105M	-$2.287M
YoY Change	-91.31%	-51.68%	12.9%
INVESTING ACTIVITIES
Capital Expenditures	$40.00K	$57.43K	-$56.95K
YoY Change	-165.68%	-200.84%	-33.82%
Acquisitions
YoY Change
Other Investing Activities	$40.00K	$42.52K
YoY Change
Cash From Investing Activities	-$10.00K	-$14.92K	-$56.95K
YoY Change	-83.58%	-73.8%	-33.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	360.0K	0.000	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-180.0K	-1.105M	-2.287M
Cash From Investing Activities	-10.00K	-14.92K	-56.95K
Cash From Financing Activities	360.0K	0.000	0.000
Net Change In Cash	170.0K	-1.120M	-2.344M
YoY Change	-107.97%	-52.22%	11.0%
FREE CASH FLOW
Cash From Operating Activities	-$180.0K	-$1.105M	-$2.287M
Capital Expenditures	$40.00K	$57.43K	-$56.95K
Free Cash Flow	-$220.0K	-$1.163M	-$2.231M
YoY Change	-89.06%	-47.87%	14.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000788611
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	SASI	Conversion Of Preferred Shares To Common Shares ConversionOfPreferredSharesToCommonShares		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable In Two Years OperatingLeasesFutureMinimumPaymentReceivableInTwoYears		usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable In Three Years OperatingLeasesFutureMinimumPaymentReceivableInThreeYears		usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable In Three Years And There After OperatingLeasesFutureMinimumPaymentReceivableInThreeYearsAndThereAfter		usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Cancelled In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Cancelled In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Weighted Average Exercise Price Warrants Forfeited Or Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38015
	dei	Entity Registrant Name EntityRegistrantName	SIGMA ADDITIVE SOLUTIONS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1865814
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3900 Paseo del Sol
	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Fe
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NM
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	87507
	dei	City Area Code CityAreaCode	(505)
	dei	Local Phone Number LocalPhoneNumber	438-2576
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	SASI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10772713	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	368443	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2845931	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45454	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	371620	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	940034	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	950943	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	137105	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	105226	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1491036	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4273720	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	227787	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	304903	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1215411	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1125285	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1443198	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1430188	usd
CY2023Q2	us-gaap	Assets Assets	2934234	usd
CY2022Q4	us-gaap	Assets Assets	5703908	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	300562	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	277492	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	127188	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	120073	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	115195	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	231633	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	542945	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	629198	usd
CY2023Q2	us-gaap	Liabilities Liabilities	542945	usd
CY2022Q4	us-gaap	Liabilities Liabilities	629198	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	316	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	316	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10772713	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10772713	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10498802	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10498802	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	10773	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10499	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54904792	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54406694	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52524277	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49342484	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2391289	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5074710	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2934234	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5703908	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	97043	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	236660	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	227202	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	288504	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	36491	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	193075	usd
	us-gaap	Cost Of Revenue CostOfRevenue	100155	usd
	us-gaap	Cost Of Revenue CostOfRevenue	233166	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	60552	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	43585	usd
	us-gaap	Gross Profit GrossProfit	127047	usd
	us-gaap	Gross Profit GrossProfit	55338	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	554182	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1184818	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1485764	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2476828	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	138489	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	167439	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	363339	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	338415	usd
CY2023Q2	SASI	Operations And Research And Development Expense OperationsAndResearchAndDevelopmentExpense	105259	usd
CY2022Q2	SASI	Operations And Research And Development Expense OperationsAndResearchAndDevelopmentExpense	146885	usd
	SASI	Operations And Research And Development Expense OperationsAndResearchAndDevelopmentExpense	231971	usd
	SASI	Operations And Research And Development Expense OperationsAndResearchAndDevelopmentExpense	290303	usd
CY2023Q2	SASI	Investor Public Relations InvestorPublicRelations	57824	usd
CY2022Q2	SASI	Investor Public Relations InvestorPublicRelations	152300	usd
	SASI	Investor Public Relations InvestorPublicRelations	112768	usd
	SASI	Investor Public Relations InvestorPublicRelations	246626	usd
CY2023Q2	SASI	Organizational Costs OrganizationalCosts	38240	usd
CY2022Q2	SASI	Organizational Costs OrganizationalCosts	60817	usd
	SASI	Organizational Costs OrganizationalCosts	89438	usd
	SASI	Organizational Costs OrganizationalCosts	119566	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	152025	usd
CY2022Q2	us-gaap	Legal Fees LegalFees	144528	usd
	us-gaap	Legal Fees LegalFees	336276	usd
	us-gaap	Legal Fees LegalFees	355944	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	94190	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	303600	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	248689	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	509032	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21470	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29861	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49597	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61445	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	202892	usd
CY2022Q2	us-gaap	Other Expenses OtherExpenses	89177	usd
	us-gaap	Other Expenses OtherExpenses	294873	usd
	us-gaap	Other Expenses OtherExpenses	176964	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1364571	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2279425	usd
	us-gaap	Operating Expenses OperatingExpenses	3212715	usd
	us-gaap	Operating Expenses OperatingExpenses	4575123	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1304019	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2235840	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3085668	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4519785	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	9	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1176	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	17	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2747	usd
	SASI	State Incentives StateIncentives	76628	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-849	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10436	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3352	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10766	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	3235	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	2070	usd
	us-gaap	Interest Expense InterestExpense	6471	usd
	us-gaap	Interest Expense InterestExpense	3389	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	35680	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4075	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11330	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	25874	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	65220	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1308094	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2247170	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3059794	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4454565	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1308094	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2247170	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3059794	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4454565	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	10688	usd
CY2022Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14220	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	22435	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	28440	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1318782	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2261390	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3082229	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4483005	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10772713	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10772713	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10498802	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10731922	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10731922	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10498802	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10772713	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10731922	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3555100	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1308094	usd
CY2023Q2	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	5794	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	138489	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2391289	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10856766	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2247170	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	11777	usd
CY2022Q2	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	21721	usd
CY2022Q2	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Employees AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToEmployees	167439	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8810533	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5074710	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3059794	usd
	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	13523	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	489	usd
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	363339	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2391289	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12859751	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12859751	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4454565	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	23490	usd
	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	43442	usd
	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Employees AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToEmployees	338415	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8810533	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8810533	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3059794	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4454565	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49597	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61445	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-326166	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-120434	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10909	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	73586	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	31879	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17197	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	23070	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	33958	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7115	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-18151	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-116438	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-372188	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2414881	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4314503	usd
	SASI	Payments For Proceeds From Property And Equipment PaymentsForProceedsFromPropertyAndEquipment	-42516	usd
	SASI	Payments For Proceeds From Property And Equipment PaymentsForProceedsFromPropertyAndEquipment	83848	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	105123	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	115197	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-62607	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-199045	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2477488	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4513548	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2845931	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11447047	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	368443	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6933499	usd
	us-gaap	Stock Issued1 StockIssued1	22435	usd
	us-gaap	Stock Issued1 StockIssued1	28440	usd
	SASI	Conversion Of Preferred Shares To Common Shares ConversionOfPreferredSharesToCommonShares	188830	usd
	SASI	Issuance Of Securities For Services IssuanceOfSecuritiesForServices	13034	usd
	SASI	Issuance Of Securities For Services IssuanceOfSecuritiesForServices	66932	usd
	us-gaap	Interest Paid Net InterestPaidNet	6471	usd
	us-gaap	Interest Paid Net InterestPaidNet	3389	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4860080	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5503336	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1318782	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2261390	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3082229	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4483005	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10772713	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10731922	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zteSJ3ndGbki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_86B_z0qA1J6SrvT6">Accounting Estimates</span></span></b> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	11337	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	28343	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	115600	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentReceivableRemainderOfFiscalYear	17006	usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable Next Twelve Months OperatingLeasesFutureMinimumPaymentReceivableNextTwelveMonths	8503	usd
CY2022Q4	SASI	Operating Leases Future Minimum Payment Receivable OperatingLeasesFutureMinimumPaymentReceivable	25509	usd
CY2023Q2	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	77208	usd
CY2023Q2	us-gaap	Property Subject To Or Available For Operating Lease Accumulated Depreciation PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation	12445	usd
CY2023Q2	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	64763	usd
CY2023Q2	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P7Y
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	257714	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	294194	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	165777	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	140723	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	516543	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	516026	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	940034	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	950943	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-89712	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-74716	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1215411	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1125285	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14996	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10993	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	15596	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	31192	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	31192	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	31192	usd
CY2022Q4	SASI	Finite Lived Intangible Assets Amortization Expense After Year Three FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree	353437	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	462609	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	316	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	316	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	363339	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	338415	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0405	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1395882	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.24
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M20D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	487473	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.50
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P4Y5M4D
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	84302	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.39
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1799053	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	433665	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.58
	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P4Y6M29D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	335059	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.60
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1897659	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.07
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M15D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	409974	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.93
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y10D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1487685	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.38
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y11M23D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1897659	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.07
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y2M15D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.35
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	387351	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y5M1D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3987931	shares
CY2021Q4	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	6.10
CY2021	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P2Y1M6D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	164652	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3823279	shares
CY2022Q4	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	4.66
CY2022	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P1Y2M8D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1490896	shares
	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.58
	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Grants Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm	P2Y7M13D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	2412086	shares
	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Weighted Average Exercise Price Warrants Forfeited Or Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled	4.54
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2902089	shares
CY2023Q2	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	2.08
	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P2Y4M2D

Files In Submission

Name	View Source	Status
0001493152-23-028422-index-headers.html	Edgar Link	pending
0001493152-23-028422-index.html	Edgar Link	pending
0001493152-23-028422.txt	Edgar Link	pending
0001493152-23-028422-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sasi-20230630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sasi-20230630_cal.xml	Edgar Link	unprocessable
sasi-20230630_def.xml	Edgar Link	unprocessable
sasi-20230630_pre.xml	Edgar Link	unprocessable
sasi-20230630_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTRP
NextTrip, Inc. Stock $ntrp

2023 Q3 Form 10-Q Financial Statement

#000149315223028422 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTRP NextTrip, Inc. Stock $ntrp

2023 Q3 Form 10-Q Financial Statement

#000149315223028422 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTRP
NextTrip, Inc. Stock $ntrp